Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Cheng

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Journal of Breath Research|February 21, 2024
Machine learning enabled detection of COVID-19 pneumonia using exhaled breath analysis: a proof-of-concept studyRuth P Cusack, Robyn Larracy, Christian B Morrell, et al.
Crisis|March 25, 2017
A Public Health Approach in Responding to the Spread of Helium Suicide in Hong KongPaul S F Yip, Qijin Cheng, Shu-Sen Chang, et al.
Circulation. Cardiovascular Quality and Outcomes|September 16, 2017
Development and Validation of Electronic Quality Measures to Assess Care for Patients With Transient Ischemic Attack and Minor Ischemic StrokeDawn M Bravata, Laura J Myers, Eric Cheng, et al.
JAMA Neurology|February 7, 2018
Quality of Care for Veterans With Transient Ischemic Attack and Minor StrokeDawn M Bravata, Laura J Myers, Greg Arling, et al.
Molecular Cancer Therapeutics|December 29, 2017
An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody-Drug Conjugate for the Treatment of Hormone Receptor-Positive Breast CancerSunil Bhakta, Lisa M Crocker, Yvonne Chen, et al.
Stroke|September 11, 2020
Factors Associated With Participation in the Chronic Disease Self-Management Program: Findings From the SUCCEED TrialAmy M Lin, Barbara G Vickrey, Frances Barry, et al.
Molecular Pharmaceutics|April 9, 2015
An anti-B7-H4 antibody-drug conjugate for the treatment of breast cancerSteven R Leong, Wei-Ching Liang, Yan Wu, et al.
Journal of Medicinal Chemistry|January 11, 2014
Fragment-based identification of amides derived from trans-2-(pyridin-3-yl)cyclopropanecarboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT)Anthony M Giannetti, Xiaozhang Zheng, Nicholas J Skelton, et al.
Molecular Cancer Therapeutics|January 7, 2012
Effects of anti-VEGF on pharmacokinetics, biodistribution, and tumor penetration of trastuzumab in a preclinical breast cancer modelCinthia V Pastuskovas, Eduardo E Mundo, Simon P Williams, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2015
Identification of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with no evidence of CYP3A4 time-dependent inhibition and improved aqueous solubilityMark Zak, Bianca M Liederer, Deepak Sampath, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Journal of Breath Research|February 21, 2024
Machine learning enabled detection of COVID-19 pneumonia using exhaled breath analysis: a proof-of-concept studyRuth P Cusack, Robyn Larracy, Christian B Morrell, et al.
Crisis|March 25, 2017
A Public Health Approach in Responding to the Spread of Helium Suicide in Hong KongPaul S F Yip, Qijin Cheng, Shu-Sen Chang, et al.
Circulation. Cardiovascular Quality and Outcomes|September 16, 2017
Development and Validation of Electronic Quality Measures to Assess Care for Patients With Transient Ischemic Attack and Minor Ischemic StrokeDawn M Bravata, Laura J Myers, Eric Cheng, et al.
JAMA Neurology|February 7, 2018
Quality of Care for Veterans With Transient Ischemic Attack and Minor StrokeDawn M Bravata, Laura J Myers, Greg Arling, et al.
Molecular Cancer Therapeutics|December 29, 2017
An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody-Drug Conjugate for the Treatment of Hormone Receptor-Positive Breast CancerSunil Bhakta, Lisa M Crocker, Yvonne Chen, et al.
Stroke|September 11, 2020
Factors Associated With Participation in the Chronic Disease Self-Management Program: Findings From the SUCCEED TrialAmy M Lin, Barbara G Vickrey, Frances Barry, et al.
Molecular Pharmaceutics|April 9, 2015
An anti-B7-H4 antibody-drug conjugate for the treatment of breast cancerSteven R Leong, Wei-Ching Liang, Yan Wu, et al.
Journal of Medicinal Chemistry|January 11, 2014
Fragment-based identification of amides derived from trans-2-(pyridin-3-yl)cyclopropanecarboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT)Anthony M Giannetti, Xiaozhang Zheng, Nicholas J Skelton, et al.
Molecular Cancer Therapeutics|January 7, 2012
Effects of anti-VEGF on pharmacokinetics, biodistribution, and tumor penetration of trastuzumab in a preclinical breast cancer modelCinthia V Pastuskovas, Eduardo E Mundo, Simon P Williams, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2015
Identification of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with no evidence of CYP3A4 time-dependent inhibition and improved aqueous solubilityMark Zak, Bianca M Liederer, Deepak Sampath, et al.
Pageof 7